Skip to main content
Home
Articles
Latest Issue
Issue Archive
Special Issues
Supplements
Categories
Conference Correspondent
ASH 2023 - CLL
SABCS 2023 - HR+/HER2- MBC
Web Exclusives
All Web Exclusives
Interview with the Innovators
Rapid Reactions
FDA Oncology Update
Videos
Press Releases
Gastrointestinal Cancer Monthly Minutes
For Authors
Author Guidelines
Symptom Management Overview
Letters to the Editor Instructions
Join Our Peer Review
Submit a Manuscript
About
About JHOP
Contact Us
Editorial Policies
Peer-Review Process
About the Editors
Editorial Board
Editorial Process
Advertising Policy
Advertise
Subscribe
Home
Articles
Latest Issue
Issue Archive
Special Issues
Supplements
Categories
Conference Correspondent
ASH 2023 - CLL
SABCS 2023 - HR+/HER2- MBC
Web Exclusives
All Web Exclusives
Interview with the Innovators
Rapid Reactions
FDA Oncology Update
Videos
Press Releases
Gastrointestinal Cancer Monthly Minutes
For Authors
Author Guidelines
Symptom Management Overview
Letters to the Editor Instructions
Join Our Peer Review
Submit a Manuscript
About
About JHOP
Contact Us
Editorial Policies
Peer-Review Process
About the Editors
Editorial Board
Editorial Process
Advertising Policy
Advertise
Cholangiocarcinoma
A Comprehensive Genomic Profiling Study Comparing Primary Tumor, Metastatic Tumor Tissue, and Liquid Biopsy in Patients with Intrahepatic CCA
Read More
Cholangiocarcinoma
PROOF Trial: A Multicenter, Open-Label Randomized, Phase 3 Trial of Infigratinib versus Gemcitabine plus Cisplatin in Patients with Advanced CCA with FGFR2 Gene Rearrangements
Read More
Cholangiocarcinoma
The Worldwide Incidence of Biliary Tract Cancer
Read More
Cholangiocarcinoma
Early Molecular Testing for Patients with CCA Crucial to Inform Treatment Choices
Read More
Cholangiocarcinoma
PFS to Systemic Therapy in Patients with CCA with FGFR2 Fusions or Rearrangements
Read More
Cholangiocarcinoma
Therapeutic Targeting of Extracellular FGFR2 Activating Deletions in Intrahepatic CCA
Read More
Cholangiocarcinoma
Futibatinib in Patients with Intrahepatic CCA Harboring FGFR2 Gene Fusions: A Phase 2 Open-Label Study (FOENIX-CCA2)
Read More
Cholangiocarcinoma
In Patients with Advanced or Metastatic Intrahepatic CCA and FGFR2 Fusions, Futibatinib Is Safe and Effective
Read More
Cholangiocarcinoma
Capecitabine and Cisplatin as Second-Line Chemotherapy for Patients with Advanced Biliary Tract Cancer
Read More
Cholangiocarcinoma
Cholangiocarcinoma Year in Review Introduction
Read More
1
2
3
4
Page 1 of 4
Results 1 - 10 of 34